4th Rx-to-OTC Switch Summit (EXL)


4th Rx-to-OTC Switch Summit (EXL)
Event on 2017-12-06 08:00:00
4th Rx-to-OTC Switch Summit Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. More than 20 products have been switched over to OTC during the past decade — and there has been a plethora of high-profile switch failures and disappointing results. Successful switches are as much an art as a science, and it has become increasingly apparent that switch teams must revise their best practices in strategy, marketing, sales, clinical research, regulatory affairs, medical writing, labeling and packaging if they are to effectively collaborate and lead an Rx product through the switch to OTC. Now in its fourth consecutive year, ExL’s Rx-to-OTC Switch Summit is the most advanced thought leadership event experts can attend to discuss all aspects of a switch, from the NDA process to the final over-the-counter product; analyze current trends; and prepare for future switches. Whether you are exploring your chances of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests, maximizing the learning experience for overcoming the shared challenges of the industry. In addition, designated lunches and networking breaks will enhance the exchange of knowledge and foster future business partnerships. Top Five Reasons to Attend Explore current trends and business models, and identify how to lead your Rx drug through the OTC switch journey Review the latest switches and learn from examples of successful and failed switches, as well as what caused their outcomes Hear how industry stakeholders can work together with key stakeholders — such as the FDA, retailers and government agencies — on the switch process and discuss the latest regulatory challenges and initiatives, including NSURE Understand the future of Rx-to-OTC switches and stay up to date with commercial strategies Network with leading industry professionals to exchange best practices for ensuring a seamless Rx-to-OTC switch, and brainstorm new marketing and branding strategies Who Should Attend This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas: Rx-to-OTC Switches Consumer Healthcare Products Marketing/Brand Management/Product Management Regulatory Affairs/Regulatory Processes Clinical Development Legal Affairs/Counsel/Regulatory Counsel Medical/Scientific Affairs Clinical Trials Research and Development Business Strategy Labeling/Packaging Drug Delivery Technology Product Development Corporate Development This event is also of interest to: Strategy and Marketing Consultants Clinical Research Labs CROs/CMOs Drug After-Market Manufacturers/Suppliers Legal/Regulatory Advisors Statistical Service Providers Marketing Organizations Agenda The 4th Rx-to-OTC Switch Summit agenda is currently under development. Sessions at this event will address a range of possible topics, such as: The current Rx-to-OTC switch market environment Rx categories that could become OTC switch areas and the next type of Rx drugs that are harder to switch Shelf strategies and consumer behavioral patterns The broad scope of issues organizations currently face during an OTC switch How to enable new switch opportunities A comparison of global Rx-to-OTC switch best practices The current regulatory landscape and the frame of NSURE and BTC in the United States Key marketing tools and strategies that require flawless execution when addressing the unique characteristics of a switch Consumer behavior studies and how they translate to label optimization Label comprehension and self-selection studies and their key objectives — the art of applying self-selection on complex indications on DFL Packaging and labeling best practices for ensuring patient safety Methods for building advocacy and neutralizing threats to your switch Rx-to-OTC, OTC-to-Rx and drug-device combination product approvals The role of patient education in creating self-efficient consumers Event Partners MEDtube MEDtube is an innovative video education platform for health professionals. It allows sharing videos and other materials with a community of more than 110,000 users worldwide, as well as building e-learning courses. The videoteque is updated daily and now contains almost 15,000 videos. PharmaLeaders PharmaLeaders.com is an online environment dedicated to enriching the careers of more than 200,000 life sciences professionals. With breaking news and informative content grouped into one of nine segmented channels, in-depth special reports, job and events postings, and so much more, industry executives, manufacturers, marketers and educators can count on PharmaLeaders for the tools they need to succeed in today’s competitive market environment. pharmaphorum.com pharmaphorum drives innovation within the pharmaceutical industry, by bringing together healthcare through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience. PharmaVOICE PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. PM360 PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the ‘360’ in our title signifies the combination of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game. Technology Networks Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas. Please contact the event manager Marilyn below for the following: – Discounts for registering 5 or more participants.- If you company requires a price quotation.Event Manager Contact: marilyn.b.turner(at)nyeventslist.comYou can also contact us if you require a visa invitation letter, after ticket purchase. We can also provide a certificate of completion for this event if required.NO REFUNDS OR TRANSFER ALLOWED ON REGISTRATIONS —————————————————————–This Event Listing is Promoted byNew York Media Technologies LLC in associationwith EXL Events Inc.http://www.NyEventsList.comhttp://www.BostonEventsList.comhttp://www.SFBayEventsList.com—————————————————————– SHU170504CEV   VJ170529Ucity  MYL170721OTH

at Sonesta Philadelphia Downtown Rittenhouse Square
1800 Market Street
Philadelphia, United States

Leave a comment